pubmed-article:21181914 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0376325 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0005767 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C1512080 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0003261 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0848332 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C2827485 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:21181914 | lifeskim:mentions | umls-concept:C0205296 | lld:lifeskim |
pubmed-article:21181914 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21181914 | pubmed:dateCreated | 2010-12-24 | lld:pubmed |
pubmed-article:21181914 | pubmed:abstractText | During recent years, vaccination against hepatitis A has been implemented in several countries. It is expected that the increase in mass vaccination against hepatitis A will eventually result in a decreased prevalence of anti-HAV antibodies in the general population. For this reason, a suitable clinical sample for diagnosis of hepatitis A must be sufficiently sensitive to enable detection of lower antibodies titers. In this study, the feasibility of using dried blood spots (DBS) was assessed for the detection of anti-HAV antibodies after a natural infection and vaccination. Seventy-four DBS and paired plasma samples were obtained from a group of college students for a cross-sectional hepatitis A seroepidemiological study. Forty-six students seronegative for anti-HAV were selected randomly and immunized with an inactivated hepatitis A vaccine using an 0-6 month schedule. Seroconversion was monitored in paired plasma and DBS samples 6 months after the first dose followed by a period of 8 and 24 months after the second dose. A strong correlation between OD/CO rates of paired plasma and DBS samples for the detection of anti-HAV was observed. The sensitivity and specificity of the DBS compared with plasma for the detection of anti-HAV antibodies after natural infection was 100%. The sensitivity of DBS in samples collected 24 months after the second dose of hepatitis A vaccine was 95.4%. The results showed that DBS samples can be used for the detection of anti-HAV antibodies both after natural infection or vaccination. | lld:pubmed |
pubmed-article:21181914 | pubmed:language | eng | lld:pubmed |
pubmed-article:21181914 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21181914 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21181914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21181914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21181914 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21181914 | pubmed:month | Feb | lld:pubmed |
pubmed-article:21181914 | pubmed:issn | 1096-9071 | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:FreireMM | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:ChouF CFC | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:VitralC LCL | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:PintoM AMA | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:RochaA MAM | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:GasparL PLP | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:MelgaçoJ GJG | lld:pubmed |
pubmed-article:21181914 | pubmed:author | pubmed-author:LimaS M BSM | lld:pubmed |
pubmed-article:21181914 | pubmed:copyrightInfo | 2010 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:21181914 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21181914 | pubmed:volume | 83 | lld:pubmed |
pubmed-article:21181914 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21181914 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21181914 | pubmed:pagination | 208-17 | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:meshHeading | pubmed-meshheading:21181914... | lld:pubmed |
pubmed-article:21181914 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21181914 | pubmed:articleTitle | The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. | lld:pubmed |
pubmed-article:21181914 | pubmed:affiliation | Department of Microbiology and Parasitology-Biomedical Institute, Federal Fluminense University, Niterói, Brazil. | lld:pubmed |
pubmed-article:21181914 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21181914 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21181914 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |